In this study, we aimed to assess the efficacy of an innovative targeted physical therapy using newly engineered bio-affinity functionalized carbon nanotubes, or BioNanofluid conjugates, in order to demonstrate in vitro, the efficacy of targeting TSHR and ablating a papillary thyroid cancer cell line. Here, TSHR is linked to thyroid gland papillary carcinoma.